SHOP: Scaffold HOPping by GRID-based similarity searches

Journal of Medicinal Chemistry

Volumn 50, Issue 11, 2007, Pages 2708-2717

  Bergmann, Rikke ^a   Linusson, Anna ^b,e   Zamora, Ismael ^c,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ASTRAZENECA R AND D   (Sweden)

^c Lead Molecular Design   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; SCAFFOLD PROTEIN;

ARTICLE; CHEMICAL STRESS; DATA BASE; MOLECULAR INTERACTION; SYNTHESIS; X RAY;

BINDING SITES; DATABASES, FACTUAL; HETEROCYCLIC COMPOUNDS; HIV PROTEASE; HUMANS; LIGANDS; MODELS, MOLECULAR; NEURAMINIDASE; ORTHOMYXOVIRIDAE; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; THROMBIN;

EID: 34250205540     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm061259g     Document Type: Article

References (62)

1. Martin, E. J.; Blaney, J. M.; Siani, M. A.; Spellmeyer, D. C.; Wong, A. K.; Moos, W. H. Measuring diversity: Experimental design of combinatorial libraries for drug discovery. J. Med. Chem. 1995, 38, 1431-1436.
2. Linusson, A.; Gottfries, J.; Lindgren, F.; Wold, S. Statistical molecular design of building blocks for combinatorial chemistry. J. Med. Chem. 2000, 43, 1320-1328.
3. Linusson, A.; Gottfries, J.; Olsson, T.; Ornskov, E.; Folestad, S.; Norden, B.; Wold, S. Statistical molecular design, parallel synthesis, and biological evaluation of a library of thrombin inhibitors. J. Med. Chem. 2001, 44, 3424-3439.
4. Sauer, W. H.; Schwarz, M. K. Molecular shape diversity of combinatorial libraries: A prerequisite for broad bioactivity. J. Chem. Inf. Comput. Sci. 2003, 43, 987-1003.
5. Schneider, G.; Neidhart, W.; Giller, T.; Schmid, G. "Scaffold- hopping" by topological pharmacophore search: A contribution to virtual screening. Angew. Chem., Int. Ed. 1999, 38, 2894-2896.
6. Abolmaali, S. F.; Ostermann, C.; Zell, A. The compressed feature matrix - A novel descriptor for adaptive similarity search. J. Mol. Model. 2003, 9, 66-75.
7. Bohl, M.; Dunbar, J.; Gifford, E. M.; Heritage, T.; Wild, D. J.; et al. Scaffold searching: Automated identification of similar ring systems for the design of combinatorial libraries. Quant. Struct.-Act. Relat. 2002, 21, 590-597.
8. Lauri, C.; Bartlett, P. A. CAVEAT: A program to facilitate the design of organic molecules. J. Comput.-Aided Mol. Des. 1994, 8, 51-66.
9. Yang, Y.; Nesterenko, D. V.; Trump, R. P.; Yamaguchi, K.; Bartlett, P. A.; Drueckhammer, D. G. Virtual hydrocarbon and combinatorial databases for use with CAVEAT. J. Chem. Inf. Model. 2005, 45, 1820-1823.
10. Lee, M. L.; Schneider, G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: Application in the design of natural product-based combinatorial libraries. J. Comb. Chem. 2001, 3, 284-289.
11. Lloyd, D. G.; Buenemann, C. L.; Todorov, N. P.; Manallack, D. T.; Dean, P. M. Scaffold hopping in de novo design. Ligand generation in the absence of receptor information. J. Med. Chem. 2004, 47, 493-496.
12. Todorov, N. P.; Dean, P. M. Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design. J. Comput.-Aided Mol. Des. 1997, 11, 175-192.
13. Chianelli, D.; Kim, Y. C.; Lvovskiy, D.; Webb, T. R. Application of a novel design paradigm to generate general nonpeptide combinatorial scaffolds mimicking beta turns: synthesis of ligands for somatostatin receptors. Bioorg. Med. Chem. 2003, 11, 5059-5068.
14. Jenkins, J. L.; Glick, M.; Davies, J. W. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. J. Med. Chem. 2004, 47, 6144-6159.
15. Zhang, Q.; Muegge, I. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: Ranking, voting, and consensus scoring. J. Med. Chem. 2006, 49, 1536-1548.
16. SHOP, v. 1.0 for Linux; Molecular Discovery Ltd.: 215 Marsh Road, HA5 5NE Pinner, Middlesex, U.K.
17. Ahlstrom, M. M.; Ridderstrom, M.; Luthman, K.; Zamora, I. Virtual screening and scaffold hopping based on GRID molecular interaction fields. J. Chem. Inf. Model. 2005, 45, 1313-1323.
18. GRID, v. 22 for Linux: Molecular Discovery Ltd.: 215 Marsh Road, HA5 5NE Pinner, Middlesex, U.K.
19. Goodford, P. J. A computational procedure for determining energetically favourable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28, 849-857.
20. Pastor, M.; Cruciani, G.; McLay, I.; Pickett, S.; Clementi, S. GRid-INdependent descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors. J. Med. Chem. 2000, 43, 3233-3243.
21. Fontaine, F.; Pastor, M.; Zamora, I.; Sanz, F. Anchor-GRIND: Filling the gap between standard 3D QSAR and the GRid-INdependent descriptors. J. Med. Chem. 2005, 48, 2687-2694.
22. Carbo, R.; Leyda, L.; Arnau, M. How similar is a molecule to another? An electron density measure of similarity between two molecular structures. Int. J. Quantum Chem. 1980, 17, 1185-1189.
23. Dolle, R. E. Comprehensive survey of combinatorial library synthesis: 1999. J. Comb. Chem. 2000, 2, 383-433.
24. Dolle, R. E. Comprehensive survey of combinatorial library synthesis: 2000. J. Comb. Chem. 2001, 3, 477-517.
25. Dolle, R. E. Comprehensive survey of combinatorial library synthesis: 2001. J. Comb. Chem. 2002, 4, 369-418.
26. Dolle, R. E. Comprehensive survey of combinatorial library synthesis: 2002. J. Comb. Chem. 2003, 5, 693-753.
27. Dolle, R. E. Comprehensive survey of combinatorial library synthesis: 2003. J. Comb. Chem. 2004, 6, 623-679.
28. Dolle, R. E. Comprehensive survey of combinatorial library synthesis: 2004. J. Comb. Chem. 2005, 7, 739-798.
29. Dolle, R. E.; Nelson, K. H., Jr. Comprehensive survey of combinatorial library synthesis: 1998. J. Comb. Chem. 1999, 1, 235-282.
30. Confort, v. 6.0 for Linux; Tripos Inc.: 1699 South Hanley Rd, St. Louis, MO 63144-2919, U.S.A.
31. Perlman, R. S.; Balducci, R. Confort: A novel algorithm for conformational analysis; National Meeting of the American Chemical Society, New Orleans, 1998; American Chemical Society: Washington, DC, 1998.
32. CombChem-DB can be downloaded from http://www.moldiscovery.com.
33. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-242.
34. St Charles, R.; Matthews, J. H.; Zhang, E.; Tulinsky, A. Bound structures of novel P3-P1′ beta-strand mimetic inhibitors of thrombin. J. Med. Chem. 1999, 42, 1376-1383.
35. Nilsson, J. W.; Kvarnstrom, I.; Musil, D.; Nilsson, I.; Samulesson, B. Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone sscaffold: Analysis of X-ray crystal structure of enzyme inhibitor complex. J. Med. Chem. 2003, 46, 3985-4001.
36. Lange, U. E.; Baucke, D.; Hornberger, W.; Mack, H.; Seitz, W.; Hoffken, H. W. D-Phe-Pro-Arg type thrombin inhibitors: Unexpected selectivity by modification of the P1 moiety. Bioorg. Med. Chem. Lett. 2003, 13, 2029-2033.
37. Wagner, J.; Kallen, J.; Ehrhardt, C.; Evenou, J. P.; Wagner, D. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors. J. Med. Chem. 1998, 41, 3664-3674.
38. Backbro, K.; Lowgren, S.; Osterlund, K.; Atepo, J.; Unge, T.; Hulten, J.; Bonham, N. M.; Schaal, W.; Karlen, A.; Hallberg, A. Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor. J. Med. Chem. 1997, 40, 898-902.
39. Abdel-Rahman, H. M.; Al-karamany, G. S.; El-Koussi, N. A.; Youssef, A. F.; Kiso, Y. HIV protease inhibitors: Peptidomimetic drugs and future perspectives. Curr. Med. Chem. 2002, 9, 1905-1922.
40. Hilgeroth, A. Dimeric 4-aryl-1,4-dihydropyridines: Development of a third class of nonpeptidic HIV-1 protease inhibitors. Mini-Rev. Med. Chem. 2002, 2, 235-245.
41. Wilson, J. C.; von Itzstein, M. Recent strategies in the search for new anti-influenza therapies. Curr. Drug Targets 2003, 4, 389-408.
42. Smith, B. J.; Colman, P. M.; Von, Itzstein, M.; Danylec, B.; Varghese, J. N. Analysis of inhibitor binding in influenza virus neuraminidase. Protein Sci. 2001, 10, 689-696.
43. Varghese, J. N.; McKimm-Breschkin, J. L.; Caldwell, J. B.; Kortt, A. A.; Colman, P. M. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 1992, 14, 327-332.
44. Sybyl, v. 6.9 for Irix; Tripos Inc.: 1699 South Hanley Rd, St. Louis, MO 63144-2919 U.S.A.
45. MAESTRO, v. 6.0 for Linux; Schrödinger LLC: New York, U.S.A.
46. Lovell, S. C.; Davis, I. W.; Arendall, W. B., III; de Bakker, P. I.; Word, J. M.; Prisant, M. G.; Richardson, J. S.; Richardson, D. C. Structure validation by Calpha geometry: phi, psi, and Cbeta deviation. Proteins 2003, 50, 437-450.
47. MacroModel, v. 8.1 for Linux; Schrödinger LLC: New York, U.S.A.
48. Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. Macromodel - An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 1990, 11, 440-467.
49. MODDE, v. 6.0 for Windows; Umetrics: Box 7960, SE-907 19 Umeå, Sweden.
50. Box, G. E. P.; Hunter, W. G.; Hunter, J. S. Statistics for experimenters. An introduction to design, data analysis and model building; John Wiley & Sons, Inc.: New York, 1978.
51. Burnham, A. J.; MacGregor, J. F.; Viveros, R. Latent variable multivariate regression modeling. Chemom. Intell. Lab. Syst. 1999, 48, 167-180.
52. Wold, S. PLS for multivariate linear modeling. Chemometric methods in molecular design; VCH: Weinheim, 1995; pp 195-218.
53. Wold, H. The basic design and some extensions. Systems under indirect observation; North-Holland Publishing company: Amsterdam, 1982; pp 1-53.
54. Stone, M. Cross-validatory choice and assessment of statistical predictions. J. R. Stat. Soc. 1974, 36B, 111-133.
55. Wold, S. Cross-validatory estimation of the numbers of components in factor and principal component models. Technometrics 1978, 20, 397-405.
56. Nelder, J. A.; Mead, R. A simplex method for function minimization. Comput. J. 1965, 7, 308-313.
57. GLIDE, v. 4.0 for Linux; Schrödinger, LLC: New York, U.S.A.
58. Wahhab, A.; Leban, J. A simple procedure for the solid phase synthesis of unsymmetrically functionalised diamides from symmetric diacids. Tetrahedron Lett. 1999, 40, 235-238.
59. Dolle, R. E.; Herpin, T. F.; Shimshock, Y. C. Solid-phase synthesis of α-hydroxy phosphonates and hydroxystatine amides. Transition-state isosteres derived from resin-bound amino acid aldehydes Tetrahedron Lett. 2001, 42, 1855-1858.
60. Carroll, C. D.; Dolle, R. E.; Shimshock, Y. C.; Herpin, T. F.; Hansen, P. E. Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases. U.S. Patent US005,962,506A, Oct. 5, 1999.
61. Cavallaro, C. L.; Herpin, T.; McGuinness, B. F.; Shimshock, Y. C.; Dolle, R. E. Allylindium and allylboronic acid pinacolate: Mild reagents for the allylation of resin-bound aldehydes. Application to the solid-phase synthesis of hydroxypropylamines Tetrahedron Lett. 1999, 40, 2711-2714.
62. Touzani, R.; Garbacia, S.; Lavastre, O.; Yadav, V. K.; Carboni, B. Efficient solution phase combinatorial access to a library of pyrazole-and triazole-containing compounds. J. Comb. Chem. 2003, 5, 375-378.